Moderna, Inc.MRNANASDAQ
Loading
Revenue Growth Under PressureDecelerating
Percentile Rank23
Year-over-Year Change
Year-over-year revenue growth rate
Percentile
P23
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -33.27% |
| Q3 2025 | 615.49% |
| Q2 2025 | 32.71% |
| Q1 2025 | -88.81% |
| Q4 2024 | -48.46% |
| Q3 2024 | 739.37% |
| Q2 2024 | 32.34% |
| Q1 2024 | -94.06% |
| Q4 2023 | 53.63% |
| Q3 2023 | 432.27% |
| Q2 2023 | -81.28% |
| Q1 2023 | -64.30% |
| Q4 2022 | 59.91% |
| Q3 2022 | -29.48% |
| Q2 2022 | -23.13% |
| Q1 2022 | -14.52% |
| Q4 2021 | 43.90% |
| Q3 2021 | 14.57% |
| Q2 2021 | 141.82% |
| Q1 2021 | 205.39% |
| Q4 2020 | 261.44% |
| Q3 2020 | 137.99% |
| Q2 2020 | 690.93% |
| Q1 2020 | -40.31% |
| Q4 2019 | -17.55% |
| Q3 2019 | 30.29% |
| Q2 2019 | -18.36% |
| Q1 2019 | -54.76% |
| Q4 2018 | -15.17% |
| Q3 2018 | 44.73% |
| Q2 2018 | -0.65% |
| Q1 2018 | -68.40% |
| Q4 2017 | 116.38% |
| Q3 2017 | 18.89% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |